11/18
01:40 pm
npce
What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]
Low
Report
What Makes NeuroPace (NPCE) a New Buy Stock [Yahoo! Finance]
11/18
11:38 am
npce
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]
Medium
Report
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade [Yahoo! Finance]
11/14
05:54 am
npce
NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
NeuroPace Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/13
12:53 pm
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.
Low
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $13.00. They now have an "overweight" rating on the stock.
11/13
02:26 am
npce
NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
High
Report
NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... [Yahoo! Finance]
11/12
05:03 pm
npce
NeuroPace Inc.: Q3 Earnings Snapshot [Yahoo! Finance]
High
Report
NeuroPace Inc.: Q3 Earnings Snapshot [Yahoo! Finance]
11/12
04:05 pm
npce
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
High
Report
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
11/9
07:37 am
npce
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week [Yahoo! Finance]
Medium
Report
private equity firms who own 45% along with institutions invested in NeuroPace, Inc. (NASDAQ:NPCE) saw increase in their holdings value last week [Yahoo! Finance]
11/4
04:19 pm
npce
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy [Yahoo! Finance]
Medium
Report
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy [Yahoo! Finance]
11/4
04:05 pm
npce
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
Medium
Report
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy
10/28
09:51 am
npce
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? [Yahoo! Finance]
Low
Report
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? [Yahoo! Finance]
10/22
04:05 pm
npce
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
Low
Report
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024
10/16
04:05 pm
npce
NeuroPace Continues to Strengthen Management Team
Low
Report
NeuroPace Continues to Strengthen Management Team
9/4
04:05 pm
npce
NeuroPace Strengthens Management Team with Two Key Appointments
Low
Report
NeuroPace Strengthens Management Team with Two Key Appointments
8/27
04:05 pm
npce
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
Low
Report
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
8/22
04:05 pm
npce
NeuroPace to Participate in Upcoming Healthcare Conferences in September
High
Report
NeuroPace to Participate in Upcoming Healthcare Conferences in September